Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
2.280
-0.140 (-5.79%)
At close: Sep 17, 2025, 4:00 PM EDT
2.280
0.00 (0.00%)
After-hours: Sep 17, 2025, 6:56 PM EDT
Beyond Air Market Cap
Beyond Air has a market cap or net worth of $11.92 million as of September 17, 2025. Its market cap has decreased by -41.79% in one year.
Market Cap
11.92M
Enterprise Value
17.09M
1-Year Change
-41.79%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since July 11, 2017, Beyond Air's market cap has decreased from $39.32M to $11.92M, a decrease of -69.69%. That is a compound annual growth rate of -13.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 12.65M | -51.13% |
| Dec 31, 2024 | 25.88M | -58.70% |
| Dec 29, 2023 | 62.67M | -67.72% |
| Dec 30, 2022 | 194.12M | -22.81% |
| Dec 31, 2021 | 251.48M | 175.14% |
| Dec 31, 2020 | 91.40M | 25.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |